Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Symphogen AsfiledCriticalSymphogen As
Publication of SG170043A1publicationCriticalpatent/SG170043A1/en
Micro-Organisms Or Cultivation Processes Thereof
(AREA)
Abstract
Disclosed are novel polyclonal antibodies, which target respiratory syncyticilal virus (RSV), and novel high affinity antibody molecules reactive with RSV. The polyclonal antibodies may comprise antibody molecules which are reactive with both RSV protein F and RSV protein G, and preferably the polyclonal antibodies target a variety of epitopes on these proteins. The single antibody molecules of the invention are shown to exhibit affinities which provide for dissocation constants as low as in the picomolar range. Also disclosed are methods of producing the antibodies of the invention as well as methods of their use in treatment for RSV infection. (Fig.7)
SG201101391-9A2006-03-062007-03-06Recombinant polyclonal antibody for treatment of respiratory syncytial virus infections
SG170043A1
(en)